Expression of Topoisomerase 1 and carboxylesterase 2 correlates with irinotecan treatment response in metastatic colorectal cancer. [electronic resource]
Producer: 20190403Description: 153-159 p. digitalISSN:- 1555-8576
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carboxylesterase -- metabolism
- Colorectal Neoplasms -- drug therapy
- DNA Topoisomerases, Type I -- metabolism
- Drug Combinations
- Female
- Fluorouracil -- therapeutic use
- Follow-Up Studies
- Gene Expression Regulation, Neoplastic
- Humans
- Irinotecan
- Kaplan-Meier Estimate
- Leucovorin -- therapeutic use
- Male
- Middle Aged
- Organometallic Compounds -- therapeutic use
- Oxaliplatin
- Prognosis
- Progression-Free Survival
- Topoisomerase I Inhibitors -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.